Leaflet RELPAX 20mg film-coated tablets


Indicated for: migraine

Route of administration: oral

Substance: eletriptan (serotonin agonist antimigraine)

ATC: N02CC06 (Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists)

Eletriptan is a medication used for the treatment of acute migraine, with or without aura. It belongs to the class of drugs known as triptans, which work by stimulating serotonin receptors to reduce inflammation and constrict blood vessels in the brain.

Eletriptan is effective in relieving migraine pain and associated symptoms such as nausea, sensitivity to light, and sound. It typically begins to work within 30 minutes to 2 hours after administration.

Common side effects include dizziness, fatigue, and a sensation of chest pressure. It is contraindicated in patients with cardiovascular diseases or uncontrolled hypertension.

Eletriptan is an effective option for patients suffering from migraines, providing rapid relief and improving their quality of life.

General data about RELPAX 20mg

  • Substance: eletriptan
  • Date of last drug list: 01-07-2015
  • Commercial code: W10701003
  • Concentration: 20mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 6
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for eletriptan

  • 20mg
  • 40mg